BLCO Stock Recent News

BLCO LATEST HEADLINES

BLCO Stock News Image - accessnewswire.com

NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.

accessnewswire.com 2025 Apr 01
BLCO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bausch Lomb Corporation ("Bausch Lomb Corporation") (NYSE:BLCO) concerning possible violations of federal securities laws. Bausch & Lomb announced a voluntary recall of intraocular lenses on its enVista platform on March 27, 2025, due to reports of toxic anterior segment syndrome (TASS), a potential complication in cataract surgery.

accessnewswire.com 2025 Mar 31
BLCO Stock News Image - accessnewswire.com

NEW YORK CITY, NY / ACCESS Newswire / March 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.

accessnewswire.com 2025 Mar 31
BLCO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bausch Lomb Corporation ("Bausch Lomb Corporation") (NYSE:BLCO) concerning possible violations of federal securities laws. Bausch & Lomb announced a voluntary recall of intraocular lenses on its enVista platform on March 27, 2025, due to reports of toxic anterior segment syndrome (TASS), a potential complication in cataract surgery.

accessnewswire.com 2025 Mar 30
BLCO Stock News Image - accessnewswire.com

NEW YORK CITY, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.

accessnewswire.com 2025 Mar 30
BLCO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bausch Lomb Corporation ("Bausch Lomb Corporation") (NYSE:BLCO) concerning possible violations of federal securities laws. Bausch & Lomb announced a voluntary recall of intraocular lenses on its enVista platform on March 27, 2025, due to reports of toxic anterior segment syndrome (TASS), a potential complication in cataract surgery.

accessnewswire.com 2025 Mar 28
BLCO Stock News Image - accessnewswire.com

NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.

accessnewswire.com 2025 Mar 28
BLCO Stock News Image - businesswire.com

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of th.

businesswire.com 2025 Mar 26
BLCO Stock News Image - seekingalpha.com

Bausch + Lomb Corporation (NYSE:BLCO ) Q4 2024 Results Conference Call February 19, 2025 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations Brent Saunders - CEO & Chairman Sam Eldessouky - Executive VP & CFO Yehia Hashad - Head of R&D and Chief Medical Officer Conference Call Participants Patrick Wood - Morgan Stanley Joanne Wuensch - Citibank Craig Bijou - Bank of America Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Denis Reznik - Raymond James Operator Greetings. Welcome to the Bausch + Lomb Fourth Quarter 2024 Earnings Call.

seekingalpha.com 2025 Feb 19
BLCO Stock News Image - zacks.com

While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com 2025 Feb 19
10 of 50